Welcome to our dedicated page for HEALTHLYNKED news (Ticker: HLYK), a resource for investors and traders seeking the latest updates and insights on HEALTHLYNKED stock.
HealthLynked Corp (OTCQB: HLYK) is revolutionizing the healthcare industry through its innovative technology platform that integrates patients with healthcare providers. By enabling a more comprehensive and connected healthcare experience, HealthLynked offers solutions such as real-time scheduling, electronic medical records, online telemedicine, emergency contact information, and medication lists and interactions. These features aim to reduce wait times and improve the accuracy and portability of medical information.
Recent achievements include the introduction of advanced search functionalities on its website and mobile applications, making it easier for patients to find and book appointments with healthcare providers even after business hours. This enhancement underscores HealthLynked's commitment to leveraging technology to improve healthcare accessibility and connectivity.
HealthLynked’s cloud-based network empowers members to actively manage their healthcare by providing a centralized, secure location for their medical data, including medications, allergies, past surgeries, and personal health records. Healthcare providers benefit from improved patient care and key insights into their practice operations. Providers who join the HealthLynked network can also utilize marketing tools to engage with patients, ensuring better compliance and optimized scheduling.
Under the leadership of CEO Dr. Michael Dent and CTO Chris Hall, HealthLynked continues to be at the forefront of healthcare innovation, striving to meet the evolving needs of both patients and providers. The company actively encourages patients to take a more active role in their healthcare by connecting them with family members and doctors through new strategies and initiatives.
For more information, visit HealthLynked Corp and stay updated through their social media channels on Facebook, Twitter, Instagram, and LinkedIn.
HealthLynked Corp. (OTCQB: HLYK) has received a $500,000 payment milestone from the sale of ACO Health Partners (AHP), representing their share of AHP's ACO shared savings for the 2023 performance period. This payment completes the total cash consideration of $3 million from the January 2023 sale, which included an initial $750,000 payment, $1.75 million in participation-based payments, and the current $500,000 milestone. The sale to Palm Beach ACO was a strategic move allowing HealthLynked to focus on its core healthcare technology and patient engagement services.
HealthLynked Corp. (OTCQB: HLYK) announced Q3 2024 financial results, revealing significant changes amid strategic restructuring. Revenue declined 56% year-over-year to $0.59 million in Q3 2024, with a nine-month revenue of $2.39 million, down 50% from 2023. The company reduced practice operating expenses by 39% to $0.80 million in Q3. Operating loss increased to $1.67 million, with a net loss of $1.97 million. The company is shifting focus from clinical operations to app-based services, with telemedicine now available nationwide. CEO Dr. Michael Dent provided $2.7 million in debt funding in 2024 to support the transition.
HealthLynked Corp has announced a significant update to its Oohvie app, integrating telemedicine services and online scheduling capabilities. The enhanced platform now offers women comprehensive healthcare management through a single mobile application. The update features a redesigned home screen, improved user interface, and expanded functionalities including virtual consultations with healthcare providers. The app follows a freemium model, with basic tracking features available for free and premium services, including telemedicine access, available through a subscription at $12 monthly or $120 annually.
HealthLynked Corp. (OTCQB: HLYK) has announced a strategic partnership with 3X4 Genetics to enhance its member offerings. This collaboration aims to provide personalized genetic insights and improved healthcare services to HealthLynked members. The partnership allows members to purchase the 3X4 Blueprint for genetic testing at $299 through HealthLynked's website.
HealthLynked CEO, Michael Dent, M.D., emphasized that this partnership demonstrates their commitment to delivering cutting-edge healthcare solutions and personalized care. 3X4 Genetics CEO, Tony Hsu, highlighted the alignment between both companies in empowering patients with genetic information for optimized health and wellness.
This collaboration is part of HealthLynked's broader strategy to expand its network of strategic alliances, focusing on improving patient health through advanced diagnostics and wellness programs. The company plans to forge similar partnerships in the coming months to increase the range of services available to its members.
HealthLynked Corp. (OTCQB: HLYK) has filed a non-provisional patent with the USPTO for ARi, an AI-powered personal healthcare assistant. ARi utilizes GPT and LLM technologies to provide personalized medical recommendations based on users' comprehensive health profiles. This innovative tool aims to address the challenge of inaccurate self-diagnosis from internet searches by incorporating patients' medical records for more tailored guidance.
Dr. Michael Dent, CEO of HealthLynked, emphasized that while ARi represents a significant advancement in patient engagement and personalized care, it is designed to supplement, not replace, professional medical consultations. The potential impact of AI in healthcare is substantial, with estimates suggesting it could save the U.S. healthcare system up to $150 billion annually by 2026.
HealthLynked Corp. (OTCQB: HLYK) has partnered with Lyric Health to launch Virtual Urgent Care, offering 24/7 telehealth services in all 50 states. Patients can connect with licensed physicians within 20 minutes for non-emergency medical concerns. The company plans to expand with Virtual Primary Care, allowing scheduled appointments with primary care physicians.
HealthLynked's comprehensive virtual care suite includes primary care, urgent care, mental health, dermatology, specialty referrals, and pet care. The service is accessible through the HealthLynked app, with visits priced at $70 or $50 for subscribers ($12/month or $120/year). This partnership aims to provide affordable and accessible healthcare nationwide, integrating with HealthLynked's existing medical record storage and prescription voucher program.
HealthLynked Corp. (OTCQB: HLYK) reported its Q2 and H1 2024 financial results, highlighting a strategic shift towards app-based technology services. Key points include:
- Q2 2024 revenue of $0.78 million, down 21% from Q1 2024 and 53% from Q2 2023
- H1 2024 revenue of $1.80 million, down 48% from H1 2023
- 42% reduction in Health Services Division operating expenses in Q2 2024
- 8% improvement in loss from operations in Q2 2024 compared to Q1 2024
- Expansion of telemedicine services nationwide
- Partnership with RxSpark for prescription drug discounts
The company is focusing on cost reduction and transitioning from clinical operations to app-based services, aiming to expand its membership base and enhance healthcare delivery.
HealthLynked Corp. (OTCQB: HLYK) has announced a strategic partnership with RxSpark to enhance medication access and management for patients. This collaboration integrates HealthLynked's advanced healthcare network with RxSpark's pharmacy discounts and prescription price comparison tool. Key benefits include:
- Enhanced prescription management
- Improved access to affordable medications
- Streamlined healthcare experience
- Cost savings for patients
HealthLynked users can access significant discount vouchers on prescription medications for free through the HealthLynked app or website. The partnership aims to provide a comprehensive healthcare solution, offering savings of up to 90% off medications and access to over 50,000 medications through RxSpark's program.
HealthLynked Corp. (OTCQB: HLYK) has announced a strategic partnership with HC Smart, Inc. to expand its telemedicine services nationwide. This expansion, set to launch within four weeks, will offer reduced-cost telemedicine consultations to HealthLynked Network members across the United States. The service will include primary care consultations, specialist services like counseling and psychiatry, and flexible appointment scheduling for both in-office and telemedicine visits.
Premium members will enjoy discounts on telemedicine services, with calls expected to cost $50, significantly less than traditional in-office visits. HealthLynked plans to introduce discounted packages for multiple visits. This expansion aligns with the growing telemedicine market, projected to reach $286 billion by 2030 with a CAGR of 24.3%, positioning HealthLynked for potential market share growth.
HealthLynked has promoted Bill Crupi to Chief Operating Officer (COO), effective immediately. This move underscores the company's commitment to operational excellence and its vision to enhance healthcare connectivity. Bill Crupi, who joined in 2023, brings over two decades of healthcare experience and has been pivotal in optimizing operational efficiencies and supporting growth. CEO Dr. Michael Dent praised Crupi's leadership and strategic insights. As COO, Crupi will focus on enhancing efficiencies, driving strategic initiatives, and improving user experiences. His leadership is expected to be important as HealthLynked aims to scale its network and introduce cutting-edge healthcare solutions.
FAQ
What is the current stock price of HEALTHLYNKED (HLYK)?
What is the market cap of HEALTHLYNKED (HLYK)?
What does HealthLynked Corp do?
What recent achievements has HealthLynked Corp made?
How does HealthLynked benefit patients?
How does HealthLynked benefit healthcare providers?
Who leads HealthLynked Corp?
What is the HealthLynked Network?
How can I stay updated with HealthLynked Corp's news?
What initiatives does HealthLynked take to enhance healthcare?
How do I join the HealthLynked Network as a healthcare provider?